Capecitabine and temozolomide in grade 1/2 neuroendocrine tumors: a Spanish multicenter experience.
about
The Role of Cytotoxic Chemotherapy in Advanced Pancreatic Neuroendocrine Tumors.Chemotherapy in NETs: When and how.The Treatment Landscape and New Opportunities of Molecular Targeted Therapies in Gastroenteropancreatic Neuroendocrine Tumors.Capecitabine and Temozolomide in Neuroendocrine Tumor of Unknown Primary.
P2860
Capecitabine and temozolomide in grade 1/2 neuroendocrine tumors: a Spanish multicenter experience.
description
2016 nî lūn-bûn
@nan
2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Capecitabine and temozolomide ...... panish multicenter experience.
@ast
Capecitabine and temozolomide ...... panish multicenter experience.
@en
type
label
Capecitabine and temozolomide ...... panish multicenter experience.
@ast
Capecitabine and temozolomide ...... panish multicenter experience.
@en
prefLabel
Capecitabine and temozolomide ...... panish multicenter experience.
@ast
Capecitabine and temozolomide ...... panish multicenter experience.
@en
P2093
P2860
P50
P356
P1433
P1476
Capecitabine and temozolomide ...... panish multicenter experience.
@en
P2093
Ana Custodio
Beatriz Nieto
Carlos López
Enrique Grande
Ignacio Matos
Isabel Sevilla
Jaume Capdevila
Miguel Navarro
Pablo Gajate
Paula Jiménez-Fonseca
P2860
P304
P356
10.2217/FON-2016-0434
P407
P577
2016-11-02T00:00:00Z